Patrizia Nanni Selected Research

Caveolin 1

1/2019	Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
4/2006	CD99 acts as an oncosuppressor in osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrizia Nanni Research Topics

Disease

52	Neoplasms (Cancer) 11/2021 - 02/2002
15	Carcinoma (Carcinomatosis) 11/2021 - 06/2003
14	Carcinogenesis 04/2019 - 02/2002
12	Neoplasm Metastasis (Metastasis) 02/2019 - 09/2006
11	Rhabdomyosarcoma 01/2021 - 07/2002
11	Breast Neoplasms (Breast Cancer) 11/2019 - 06/2004
6	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 03/2002
4	Hypoxia (Hypoxemia) 01/2021 - 10/2011
4	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 04/2006
2	Hepatitis B 01/2018 - 10/2010
2	Communicable Diseases (Infectious Diseases) 06/2015 - 10/2010
2	Neoplasm Micrometastasis 09/2010 - 02/2006
2	Sarcoma (Soft Tissue Sarcoma) 02/2010 - 03/2006
1	Noncommunicable Diseases 01/2018
1	Papilloma (Papillomatosis) 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Virus Diseases (Viral Diseases) 07/2012
1	Carcinoma in Situ 12/2011
1	Tetanus 10/2010
1	Brain Neoplasms (Brain Tumor) 06/2009

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 04/2019 - 06/2004
12	AntibodiesIBA 01/2021 - 02/2002
11	Interleukin-12 (IL 12)IBA 01/2018 - 02/2002
6	Biological ProductsIBA 11/2019 - 11/2009
6	Monoclonal AntibodiesIBA 01/2018 - 07/2002
5	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 02/2005
5	Insulin-Like PeptidesIBA 04/2019 - 09/2006
5	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2002
5	AntigensIBA 01/2013 - 06/2004
5	CytokinesIBA 07/2011 - 06/2004
4	Trastuzumab (Herceptin)FDA Link 01/2019 - 05/2014
4	Oncogene Proteins (Oncogene Protein)IBA 08/2017 - 11/2004
4	Cancer VaccinesIBA 05/2014 - 11/2007
4	Interferon-gamma (Interferon, gamma)IBA 03/2009 - 06/2003
3	human ERBB2 proteinIBA 04/2019 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2006
3	Epidermal Growth Factor (EGF)IBA 01/2018 - 07/2002
3	Mitochondrial DNA (mtDNA)IBA 03/2014 - 10/2011
3	Tamoxifen FDA LinkGeneric 12/2011 - 06/2003
3	Myosins (Myosin)IBA 04/2009 - 06/2003
2	EnzymesIBA 01/2021 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
2	Neutralizing AntibodiesIBA 02/2019 - 03/2002
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2007
2	Caveolin 1IBA 01/2019 - 04/2006
2	CarcinogensIBA 01/2018 - 02/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 09/2006
2	Protein Isoforms (Isoforms)IBA 08/2017 - 11/2014
2	Interleukin-15 (Interleukin 15)IBA 05/2015 - 06/2004
2	ErbB-2 ReceptorIBA 05/2014 - 11/2010
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 03/2014 - 03/2013
2	DNA VaccinesIBA 01/2014 - 12/2013
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014 - 07/2011
2	LigandsIBA 07/2012 - 08/2007
2	InterleukinsIBA 11/2007 - 06/2004
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2007 - 03/2002
2	Connective Tissue Growth FactorIBA 01/2007 - 03/2004
1	ClaudinsIBA 11/2021
1	Sunitinib (Sutent)FDA Link 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 04/2019
1	Phosphotransferases (Kinase)IBA 04/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	MC3343IBA 01/2018
1	quinolineIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	PerforinIBA 05/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	AgarIBA 03/2013
1	pimonidazoleIBA 03/2013
1	Genetic Markers (Genetic Marker)IBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 07/2012
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2012
1	NVP-BKM120IBA 01/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2011
1	Succinic Acid (Succinate)IBA 10/2011
1	DeoxyribonucleotidesIBA 07/2011
1	ProteomeIBA 11/2010
1	AutoantibodiesIBA 11/2010
1	Viral VaccinesIBA 09/2010
1	dactolisibIBA 02/2010

Therapy/Procedure

15	Therapeutics 01/2021 - 07/2002
6	Immunotherapy 01/2018 - 02/2005
2	Aftercare (After-Treatment) 01/2021 - 02/2007
1	Intravenous Injections 02/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Tertiary Prevention 06/2015
1	Chemoprevention 12/2011
1	Oncolytic Virotherapy 06/2009